PP
BLFS icon

PDT Partners’s BioLife Solutions BLFS Stock Holding History

PDT Partners’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-61,109
Closed -$2.28M – 944
2021
Q4 		$2.28M Buy
61,109
+18,609
+44% +$799K 0.17% 216
2021
Q3 		$1.8M Buy
42,500
+9,581
+29% +$461K 0.13% 259
2021
Q2 		$1.47M Buy
+32,919
New +$1.16M 0.1% 307

Other funds holding BLFS

CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
GCM
Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

PDT Partners's BLFS Position: Q1 2022 in Review

PDT Partners sold out of BioLife Solutions (BLFS) in Q1 2022, closing a stake of 61,109 shares — an estimated $2.28M sold.

PDT Partners first reported a position in BLFS in Q2 2021 and held it in 3 quarters. The position peaked at $2.28M in Q4 2021. 164 funds tracked by Wall St. Rank hold BLFS as of Q1 2022.

  • PDT Partners reported no remaining BioLife Solutions position as of Q1 2022 after selling out during the quarter.
  • PDT Partners sold 61,109 BioLife Solutions shares in Q1 2022, an estimated $2.28M.
  • PDT Partners first reported a position in BioLife Solutions in Q2 2021 and held it in 3 quarters.
  • PDT Partners's BioLife Solutions position peaked at $2.28M in Q4 2021.
  • 164 funds tracked by Wall St. Rank held BioLife Solutions as of Q1 2022.

Based on PDT Partners's 13F filing for Q1 2022, filed 16 May 2022.